STAT1 and Alzheimer disease: In conclusion, miR-146a inhibition promoted total neurite outgrowth and suppressed cell apoptosis, inflammation, as well as STAT1/MYC pathway in PC12 and cortical neuron cellular AD models, which could indicate miR-146a as a potential therapeutic target for AD.